Street Abandons Genocea On Strategic Shift, CEO Says Oncology Focus Wasn't Sudden

By: via Benzinga
Genocea Biosciences Inc (NASDAQ: GNCA) announced a 40-percent workforce reduction Monday as it officially shifts focus to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.